Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fisher Paykel Healthcare | New Zealand | Healthcare | Healthcare Equipment & Supplies | NZ$21.68B | 121.1x | NZ$37.14 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.8% Downside | Upgrade to Pro+ | ||
Ryman Healthcare | New Zealand | Healthcare | Healthcare Providers & Services | NZ$2.95B | -36x | 0.26 | NZ$4.33 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.7% Upside | Upgrade to Pro+ | |
Oceania Healthcare | New Zealand | Healthcare | Healthcare Providers & Services | NZ$535.58M | -25.5x | 0.17 | NZ$0.71 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.2% Upside | Upgrade to Pro+ | |
AFT Pharma | New Zealand | Healthcare | Pharmaceuticals | NZ$293M | 27.4x | -0.79 | NZ$2.85 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.7% Upside | Upgrade to Pro+ | |
Radius Residential Care | New Zealand | Healthcare | Healthcare Providers & Services | NZ$53.28M | -7.2x | 0.03 | NZ$0.19 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cannasouth | New Zealand | Healthcare | Biotechnology & Medical Research | NZ$32.39M | -2.8x | -0.13 | NZ$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Promisia Healthcare | New Zealand | Healthcare | Healthcare Providers & Services | NZ$21.30M | 2.3x | 0 | NZ$0.41 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Truscreen | New Zealand | Healthcare | Healthcare Equipment & Supplies | NZ$14.37M | -6.5x | -0.19 | NZ$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rua Bioscience | New Zealand | Healthcare | Pharmaceuticals | NZ$4.09M | -0.5x | 0 | NZ$0.02 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Greenfern Industries | New Zealand | Healthcare | Healthcare Providers & Services | NZ$2.52M | 2.3x | NZ$0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |